Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesAntiplatelet Intervention in Acute Coronary Syndrome
American Journal of Therapeutics, 09/29/09
Arora RR et al. – Data from CRUSADE suggests that the majority of patients are likely to benefit from aggressive upstream antithrombotic therapy. Patients with ACS who have diabetes have a higher risk for recurrent events than their nondiabetic counterparts but stand to benefit more from early aggressive therapy. Combining GP IIb/IIIa inhibition with drug–eluting stents offers the potential to optimize outcomes after revascularization in patients with diabetes. Whereas the use of drug–eluting stents has greatly reduced the risk of restenosis, patients with diabetes who have ACS and who undergo stenting remain at high risk for restenosis and are more likely to require revascularization. Increasing adherence to American College of Cardiology/American Heart Association guidelines is key to improving outcomes. The optimal management of patients with ACS continues to change as new therapies and strategies of care are developed and proven effective. The clinical challenge remains to increase physician adherence to evidence–based cardiac care for all patients.
Related Articles
Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09
Relevance Score: 95%
Management of acute coronary syndrome in a case of Behcets disease
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 89%
Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome
Thrombosis Research, 10/26/09
Relevance Score: 89%
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome
Nutrition, Metabolism & Cardiovascular Diseases, 10/19/09
Relevance Score: 89%
Predictive Values of Post-Treatment Adenosine Diphosphate–Induced Aggregation and Vasodilator-Stimulated Phosphoprotein Index for Stent Thrombosis After Acute Coronary Syndrome in Clopidogrel-Treated Patients
The American Journal of Cardiology, 10/15/09
Relevance Score: 89%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies
British Medical Journal, 12/07/09
Thirty-five-year trends in cardiovascular risk factors in Finland
International Journal of Epidemiology, 12/07/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Gabapentin Enacarbil in Restless Legs Syndrome: A Phase 2b, 2-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Clinical Neuropharmacology, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Today in Critical Care/Hospitalist...keeping you current
Receive free subspecialty "5-minute updates" via email
Chest pain in a young basketball player
Journal of General Internal Medicine, 12/07/09
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
JAMA, 12/02/09
Evidence lost to treatment of critically-ill patients
Minerva Anestesiologica, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor